期刊文献+

血浆NT-proBNP水平对射频导管消融术后房颤复发的影响 被引量:4

Effect of plasma N-terminal pro-brain natriuretic peptide on recurrence of atrial fibrillation after radiofrequency catheter ablation
原文传递
导出
摘要 目的探讨血浆N末端B型利钠肽原(NT-proBNP)水平对射频导管消融术(RFCA)后房颤复发的影响。方法 65例阵发性房颤患者行RFCA,术后随访3个月,分为成功组(A组,54例)和复发组(B组,11例)。ELISA法检测两组治疗前和治疗后1、2和3个月血浆NT-proBNP水平。结果 B组术前血浆NT-proBNP明显高于A组[(200.7±36.3)ng/L vs.(164.5±45.4)ng/L](P<0.05),且术后NT-proBNP下降率也明显小于A组[(12.0±5.9)%vs.(23.8±5.5)%](P<0.05)。术前血浆NT-proBNP>188.1ng/L和术后NT-proBNP下降率<18.7%为RFCA术后房颤复发的独立危险因素(P<0.05);后者用于预测RFCA术后房颤复发的价值更大(P<0.05)。结论阵发性房颤患者术前血浆NT-proBNP水平升高和术后下降不明显均提示RFCA后房颤复发可能性大,后者预测价值更大。 Objective To explore the effect of level of plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) on the recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation(RFCA). Methods Sixty-five patients with paroxysmal AF underwent RFCA were divided into groups of A(without recurrence of AF,54 cases) and B(with recurrence of AF, 11 cases) based on 3-month follow up after operation. Plasma NT-proBNP before and on the Ist , 2nd, and 3rd month after treatment was detected by ELISA in two groups. Results Plasma NT-proBNP before RFCA was higher in group B than that in group AF(200.7±36.3) ng/L vs. (164.5±45.4) ng/L](P〈0. 05). The decline rate of NT-proBNP level after RFCA was lower in group B than that in group A[(12. 0± 5.9)% vs. (23.8 ± 5.5)] (P(0. 05). Plasma NT-proBNP was higher than 188. 1 ng/L before RFCA and its decline rate was lower than 18. 7± after RFCA were the independent risk factors for the recurrence of AF after operation (P〈0. 05). The latter was more valuable than the formal in predicting the recurrence of AF after operation(P〈0. 05). Conclusion AF is more likely to recur in the patients with higher level of plasma NT-proBNP before and with lower decline rate of NT-proBNP after RFCA, especially in the latter.
出处 《江苏医药》 CAS 北大核心 2013年第23期2863-2865,共3页 Jiangsu Medical Journal
关键词 N末端B型利钠肽原 心房颤动 射频导管消融术 N-terminal pro-brain natriuretic peptide~ Atrial fibrillation Radiofrequency catheter ablation
  • 相关文献

参考文献10

  • 1全文超,杨承健,徐欣,曹佳宁,张月军,杨政杰,金艳.培哚普利联用胺碘酮对阵发性心房颤动ANP、NT-ProBNP、hs-CRP的影响[J].江苏医药,2011,37(23):2844-2845. 被引量:1
  • 2Asselbergs FW, van den Berg MP, Bakker SJ, et al. N-termi- nal pro-B-type natriuretie peptide levels predict newly detec- ted atrial fibrillation in a population-based cohort[J]. Neth Heart J, 2008,16(3) : 73-78.
  • 3Buccelletti F,Gilardi E,Marsiliani D,et al. Predictive value of NT-proBNP for cardioversion in a new onset atrial fibrillation [J]. Eur J Emerg Med, 2011,18(3) : 157-161.
  • 4Hwang HJ, Son JW, Nam BH, et al. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic pep- tide for short-term recurrence in atrial fibrillation ablation [J]. Clin Res Cardiol, 2009,98 (4): 213-218.
  • 5MacDonald MR,Connelly DT, Hawkins NM, et al. Radiofre- quency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial[J]. Heart, 2011,97 (9) :740-747.
  • 6Marsiliani D, Buccelletti F, Carroecia A, et al. Natriuretic pep- tides and atrial fibrillation[J]. Eur Rev Med Pharmacol Sci, 2010,14(10) : 855-860.
  • 7Kim WS,Park SH. Correlation between N-terminal pro-brain natriuretic peptide and Doppler echocardiographic parameters of left ventricular filling pressure in atrial fibrillation[J]. J Cardiovasc Ultrasound, 2011,19 (1) : 26-31.
  • 8Solheim E, Off MK, Hoff PI, et al. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation., a marker of reverse atrial remodelling and successful ablation[J]. J Interv Card Electrophysiol, 2012,34 (2),129-136.
  • 9Costello-Boerrigter LC, Boerrigter G, Redfield MM, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction[J]. J Am Coil Cardiol, 2006,47(2) : 345-353.
  • 10Watson T, Arya A, Sulke N, et al. Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation[J]. Chest, 2010, 137 (4) : 869- 876.

二级参考文献5

  • 1Yin Y, Dalal D, Liu Z, et al. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation[J]. Eur Heart J,2006,27(15) : 1841-1846.
  • 2Willems R, Sipido KR, Holemans P, et al. Different pattems of angiotensin Ⅱ and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2001,12(12) : 1387-1392.
  • 3Nakashima H, Kumagai K, Urata H, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation [J]. Circulation, 2000,101(22): 2612-2617.
  • 4Lopez B, Querejeta R, Varo N, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type 1 in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients [J]. Circulation, 2001, 104 (3): 286-291.
  • 5Mabuchi N, Tsutamoto T, Maeda K, et al. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure[J]. Jpn Circ J,2000,64(10) :765-771.

同被引文献33

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部